Cargando…
Transcriptional CDK Inhibitors as Potential Treatment Option for Testicular Germ Cell Tumors
SIMPLE SUMMARY: Type II testicular germ cell tumors are a severe type of cancer in young men demanding alternative treatment options to conventional chemotherapy with less side effects. In particular, patients with chemotherapy-resistant tumors face a bad prognosis and low survival rates. In other t...
Autores principales: | Funke, Kai, Düster, Robert, Wilson, Prince De-Graft, Arévalo, Lena, Geyer, Matthias, Schorle, Hubert |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8997165/ https://www.ncbi.nlm.nih.gov/pubmed/35406461 http://dx.doi.org/10.3390/cancers14071690 |
Ejemplares similares
-
Genome-scale CRISPR screen reveals neddylation to contribute to cisplatin resistance of testicular germ cell tumours
por: Funke, Kai, et al.
Publicado: (2023) -
The bromodomain inhibitor JQ1 triggers growth arrest and apoptosis in testicular germ cell tumours in vitro and in vivo
por: Jostes, Sina, et al.
Publicado: (2016) -
Functional characterization of the human Cdk10/Cyclin Q complex
por: Düster, Robert, et al.
Publicado: (2022) -
The plasticity of germ cell cancers and its dependence on the cellular microenvironment
por: Nettersheim, Daniel, et al.
Publicado: (2017) -
Testicular germ cell tumors
por: Albers, Peter
Publicado: (2021)